Yalei Lv
About
In The Last Decade
Yalei Lv
20 papers receiving 341 citations
Peers
Comparison fields: 5 of 50
- Molecular Biology 237
- Cancer Research 198
- Oncology 94
- Pulmonary and Respiratory Medicine 66
- Surgery 34
Countries citing papers authored by Yalei Lv
This map shows the geographic impact of Yalei Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yalei Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yalei Lv more than expected).
Fields of papers citing papers by Yalei Lv
This network shows the impact of papers produced by Yalei Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yalei Lv. The network helps show where Yalei Lv may publish in the future.
Co-authorship network of co-authors of Yalei Lv
This figure shows the co-authorship network connecting the top 25 collaborators of Yalei Lv. A scholar is included among the top collaborators of Yalei Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yalei Lv. Yalei Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 10 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 4 | |
| 6 | 10 | |
| 7 | 2 | |
| 8 | 2 | |
| 9 | 71 | |
| 10 | 6 | |
| 11 | 0 | |
| 12 | Bevacizumab followed by chemotherapy is potential therapy for gastric cancer. | 4 |
| 13 | 5 | |
| 14 | 33 | |
| 15 | 29 | |
| 16 | 11 | |
| 17 | 25 | |
| 18 | 68 | |
| 19 | 48 | |
| 20 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.